• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why Okta Shares Are Trading Higher By Around 24%; Here Are 20 Stocks Moving Premarket

    2/29/24 8:04:20 AM ET
    $AI
    $BCAN
    $BFLY
    $COCH
    Computer Software: Prepackaged Software
    Technology
    Computer Software: Prepackaged Software
    Technology
    Get the next $AI alert in real time by email

    Shares of Okta, Inc. (NASDAQ:OKTA) shares rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.

    Okta reported quarterly earnings of 63 cents per share which beat the analyst consensus estimate of 51 cents. Quarterly sales came in at $605 million which beat the analyst consensus estimate of $587.5 million, according to data from Benzinga Pro.

    Okta shares jumped 23.6% to $107.90 in pre-market trading

    Here are some other stocks moving in pre-market trading.

    Gainers

    • Volcon, Inc. (NASDAQ:VLCN) gained 138% to $2.88 in pre-market trading after surging around 39% on Wednesday.
    • Societal CDMO, Inc. (NASDAQ:SCTL) shares rose 134.7% to $1.08 in pre-market trading as the company agreed to be acquired by CoreRx, Inc.
    • J-Long Group Limited (NASDAQ:JL) shares surged 38.1% to $17.67 in pre-market trading after dipping over 20% on Wednesday.
    • Voyager Therapeutics, Inc. (NASDAQ:VYGR) gained 24.4% to $11.16 in pre-market trading after the company reported better-than-expected fourth-quarter financial results.
    • Nxu, Inc. (NASDAQ:NXU) shares rose 21.8% to $0.8649 in pre-market trading. Nxu said it fully regained compliance with Nasdaq's continued listing requirements.
    • Duolingo, Inc. (NASDAQ:DUOL) gained 21.1% to $236.72 in pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.
    • C3.ai, Inc. (NYSE:AI) shares gained 15.8% to $34.40 in pre-market trading after the company reported better-than-expected third-quarter financial results.
    • Indaptus Therapeutics, Inc. (NASDAQ:INDP) rose 15.6% to $2.29 in pre-market trading.
    • NFT Limited (NYSE:MI) shares jumped 15% to $0.2530 in pre-market trading.

    Losers

    • BYND Cannasoft Enterprises Inc. (NASDAQ:BCAN) shares dipped 25.2% to $0.1522 in pre-market trading. BYND Cannasoft is entering into production agreements for its EZ-G Device.
    • Snowflake Inc. (NYSE:SNOW) shares tumbled 23% to $177.17. Snowflake reported upbeat earnings for its fourth quarter. The company said CEO Frank Slootman has decided to retire from his role as CEO but will continue to serve as chairman of the board. Sridhar Ramaswamy has been appointed as CEO and a member of the board, effective immediately.
    • WW International, Inc. (NASDAQ:WW) fell 21.9% to $2.98 in pre-market trading after the company reported fourth-quarter financial results and announced that director Oprah Winfrey has decided not to stand for re-election at the company's upcoming annual meeting of shareholders.
    • Envoy Medical, Inc. (NASDAQ:COCH) shares declined 19.7% to $2.82 in pre-market trading after jumping 190% on Wednesday.
    • Butterfly Network, Inc. (NASDAQ:BFLY) fell 18.2% to $1.21 in pre-market trading after the company reported mixed fourth-quarter financial results.
    • ESGL Holdings Limited (NASDAQ:ESGL) fell 17.6% to $0.38 pre-market trading after gaining over 5% on Wednesday.
    • Shoals Technologies Group, Inc. (NASDAQ:SHLS) shares dipped 17.6% to $12.68 in pre-market trading after the company reported worse-than-expected fourth-quarter financial results and issued FY24 revenue guidance below estimates.
    • Milestone Pharmaceuticals Inc. (NASDAQ:MIST) shares fell 15% to $1.81 in pre-market trading after announcing a proposed public offering of common shares and pre-funded warrants.
    • Schrödinger, Inc. (NASDAQ:SDGR) shares fell 15% to $26.66 in pre-market trading after the company reported mixed fourth-quarter financial results.
    • LivePerson, Inc. (NASDAQ:LPSN) shares declined 14.6% to $2.05 in pre-market trading following fourth-quarter financial results.

     

    Now Read This: HP, Best Buy And 3 Stocks To Watch Heading Into Thursday

    Get the next $AI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $AI
    $BCAN
    $BFLY
    $COCH

    CompanyDatePrice TargetRatingAnalyst
    Okta Inc.
    $OKTA
    3/19/2026$100.00Outperform
    Macquarie
    Duolingo Inc.
    $DUOL
    3/18/2026Buy → Hold
    Argus
    Okta Inc.
    $OKTA
    3/6/2026$97.00Market Perform → Outperform
    BMO Capital Markets
    Okta Inc.
    $OKTA
    3/3/2026$76.00Equal Weight
    Wells Fargo
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Hold
    Truist
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Buy → Neutral
    BofA Securities
    Duolingo Inc.
    $DUOL
    2/27/2026$100.00Sector Outperform → Sector Perform
    Scotiabank
    Duolingo Inc.
    $DUOL
    2/27/2026$95.00Overweight → Neutral
    Analyst
    More analyst ratings

    $AI
    $BCAN
    $BFLY
    $COCH
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by WW International Inc.

    SCHEDULE 13G/A - WW INTERNATIONAL, INC. (0000105319) (Subject)

    3/26/26 11:05:13 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    C3.ai Inc. filed SEC Form 8-K: Other Events

    8-K - C3.ai, Inc. (0001577526) (Filer)

    3/24/26 8:35:42 PM ET
    $AI
    Computer Software: Prepackaged Software
    Technology

    Indaptus Therapeutics Inc. filed SEC Form 8-K: Changes in Control of Registrant, Entry into a Material Definitive Agreement, Leadership Update, Financial Statements and Exhibits

    8-K - Indaptus Therapeutics, Inc. (0001857044) (Filer)

    3/24/26 4:30:11 PM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AI
    $BCAN
    $BFLY
    $COCH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Mckinnon Todd

    4 - Okta, Inc. (0001660134) (Issuer)

    3/25/26 5:02:39 PM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Sabino Anthony John

    4 - LIVEPERSON INC (0001102993) (Issuer)

    3/25/26 4:28:26 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    SEC Form 4 filed by Ho Emily

    4 - Snowflake Inc. (0001640147) (Issuer)

    3/24/26 8:12:24 PM ET
    $SNOW
    Computer Software: Prepackaged Software
    Technology

    $AI
    $BCAN
    $BFLY
    $COCH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Macquarie initiated coverage on Okta with a new price target

    Macquarie initiated coverage of Okta with a rating of Outperform and set a new price target of $100.00

    3/19/26 8:26:35 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    Duolingo downgraded by Argus

    Argus downgraded Duolingo from Buy to Hold

    3/18/26 8:20:46 AM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    Okta upgraded by BMO Capital Markets with a new price target

    BMO Capital Markets upgraded Okta from Market Perform to Outperform and set a new price target of $97.00

    3/6/26 8:20:09 AM ET
    $OKTA
    Computer Software: Prepackaged Software
    Technology

    $AI
    $BCAN
    $BFLY
    $COCH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Envoy Medical Reports Full Year 2025 Financial Results

    Received FDA approval to expand fully implanted Acclaim® Cochlear Implant Pivotal Clinical Trial to final stageStrengthened balance sheet by extinguishing $32 million in debtSubsequent to year-end, closed on transformational capital raise led by established institutional healthcare investors and completed enrollment of Pivotal Clinical Trial for first-of-its-kind fully implanted cochlear implantWhite Bear Lake, Minnesota--(Newsfile Corp. - March 23, 2026) - Envoy Medical® Inc. (NASDAQ:COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced its corporate and financial results for the full year ended December 31, 2025, as

    3/23/26 8:30:00 AM ET
    $COCH
    Industrial Specialties
    Health Care

    Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT

    FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in clinical studies were 2x more likely to convert symptomatic PSVT to sinus rhythm and did so more than 3x faster compared with placeboCARDAMYST launch execution on track with positive initial engagement in the product from healthcare providers and payers $200 million pro forma cash supports strong launch and operating runway into late 2027; includes $106 million of cash at year-end and net proceeds from subsequent financing activities1Company to host investor call and webcast at 8:30am ET today MONTREAL and CHARLOTTE, N.C., March 20, 2026 (GLOBE

    3/20/26 7:12:14 AM ET
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    The $308B Security Pivot: Reshaping Digital Safety for the Quantum Age

    VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Cybersecurity is hitting a massive turning point. Global spending is hitting $308 billion this year, reflecting a structural shift as companies race to lock down their AI-driven architectures[1]. It is no longer about stopping tomorrow's threats; hackers are stealing encrypted data right now, hoping to unlock it once the technology catches up[2]. This immediate cryptographic exposure is placing a high premium on firms like Quantum Secure Encryption Corp. (CSE:QSE) (OTCQB:QSEGF) (FSE: VN8), Kyndryl (NYSE:KD), Okta (NASDAQ:OKTA), Mitek Systems (NASDAQ:MITK), and Clear Secure (NYSE:YOU). The

    3/19/26 11:45:16 AM ET
    $KD
    $MITK
    $OKTA
    EDP Services
    Technology
    Computer peripheral equipment
    Computer Software: Prepackaged Software

    $AI
    $BCAN
    $BFLY
    $COCH
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Director Shelton James H bought $498,792 worth of shares (5,000 units at $99.76), increasing direct ownership by 108% to 9,632 units (SEC Form 4)

    4 - Duolingo, Inc. (0001562088) (Issuer)

    3/4/26 4:49:44 PM ET
    $DUOL
    Computer Software: Prepackaged Software
    Technology

    Director Patel Mona Chetan bought $125,000 worth of shares (312,500 units at $0.40), increasing direct ownership by 1,562% to 332,500 units (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:51:51 PM ET
    $COCH
    Industrial Specialties
    Health Care

    Interim CFO Potashnick Robert bought $85,000 worth of shares (212,500 units at $0.40) (SEC Form 4)

    4 - Envoy Medical, Inc. (0001840877) (Issuer)

    2/17/26 4:49:33 PM ET
    $COCH
    Industrial Specialties
    Health Care

    $AI
    $BCAN
    $BFLY
    $COCH
    Leadership Updates

    Live Leadership Updates

    View All

    RESAAS Appoints Michael Dziekan as Director of Data Strategy

    VANCOUVER, BC, March 12, 2026 /CNW/ - RESAAS Services Inc. ("RESAAS") (TSXV:RSS) (OTCQB:RSASF), a leading provider of technology solutions for the real estate industry, is pleased to announce the appointment of Michael Dziekan as Director of Data Strategy. Dziekan will lead RESAAS' data strategy initiatives, focused on expanding the Company's data partnerships, enhancing its global real estate data infrastructure, driving new opportunities for data-driven products and services across the RESAAS platform.Dziekan brings extensive global experience in real estate data, analytics, a

    3/12/26 8:30:00 AM ET
    $IBM
    $SNOW
    Computer Manufacturing
    Technology
    Computer Software: Prepackaged Software

    Butterfly Network Appoints David Horsley as Senior Vice President, Innovation – Butterfly Embedded™

    Chirp Microsystems Co-Founder Joins Butterfly to Advance its Ultrasound-on-Chip™ Platform Strategy Butterfly Network, Inc. (NYSE:BFLY) ("Butterfly"), a pioneer and leader in semiconductor-based ultrasound devices, programmable cloud software and AI, today announced the appointment of David Horsley, Ph.D. as Senior Vice President of Innovation – Butterfly Embedded™ to scale its Ultrasound-on-Chip™ co-development and licensing initiative. In this role, Dr. Horsley will lead strategy and go-to-market for Butterfly Embedded, overseeing new product development, partnerships, and commercialization efforts. Butterfly Embedded is focused on extending the reach of the company's proprietary semic

    3/10/26 8:05:00 AM ET
    $BFLY
    Medical Electronics
    Health Care

    Milestone Pharmaceuticals Appoints David Sandoval as General Counsel and Chief Compliance Officer

    MONTREAL and CHARLOTTE, N.C., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Milestone Pharmaceuticals Inc. (NASDAQ:MIST) today announced the appointment of David Sandoval as General Counsel and Chief Compliance Officer. Mr. Sandoval's appointment comes as Milestone launches CARDAMYST™ (etripamil) nasal spray, the first and only approved self-administered treatment for the conversion of acute symptomatic episodes of paroxysmal supraventricular tachycardia (PSVT) to sinus rhythm in adults. CARDAMYST was approved by the U.S. Food and Drug Administration (FDA) on December 12, 2025. He will serve as a member of Milestone's executive leadership team and will provide business-focused legal counsel across all

    2/10/26 8:00:00 AM ET
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $AI
    $BCAN
    $BFLY
    $COCH
    Financials

    Live finance-specific insights

    View All

    Milestone Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Update on the Commercial Launch of CARDAMYST™ (etripamil) Nasal Spray for the Treatment of PSVT

    FDA approval of CARDAMYST represents first new option in 30 years for the more than two million patients with PSVTParticipants using CARDAMYST in clinical studies were 2x more likely to convert symptomatic PSVT to sinus rhythm and did so more than 3x faster compared with placeboCARDAMYST launch execution on track with positive initial engagement in the product from healthcare providers and payers $200 million pro forma cash supports strong launch and operating runway into late 2027; includes $106 million of cash at year-end and net proceeds from subsequent financing activities1Company to host investor call and webcast at 8:30am ET today MONTREAL and CHARLOTTE, N.C., March 20, 2026 (GLOBE

    3/20/26 7:12:14 AM ET
    $MIST
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Weight Watchers Announces Fourth Quarter and Full Year 2025 Results

    2025 Total Revenue and Adjusted EBITDA1,2 above high end of previously provided guidance Total End of Period Subscribers of 2.8 million; End of Period Clinical Subscribers of 130 thousand, up 42% year-over-year with continued growth in first quarter 2026  Fourth Quarter Total Revenue of $163 million; Clinical Subscription Revenue of $27 million, up 32% year-over-year Fourth Quarter Net Loss of $6 million; Net Loss Margin of 3.6%; Adjusted EBITDA1 of $18 million and Adjusted EBITDA Margin1 of 11.1% Provides First Quarter 2026 End of Period Subscriber Estimates and Full Year 2026 Financial Guidance NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ:WW) ("Weigh

    3/16/26 7:00:00 AM ET
    $WW
    Other Consumer Services
    Consumer Discretionary

    LivePerson Announces Fourth Quarter 2025 Financial Results

    -- Total Revenue of $59.3 million, above the high-end of our guidance range ---- Adjusted EBITDA above the high-end of our guidance range  --NEW YORK, March 12, 2026 /PRNewswire/ -- LivePerson, Inc. (NASDAQ:LPSN) ("LivePerson" the "Company", "we" or "us"), a leading provider of predictable conversational AI, today announced financial results for the fourth quarter ended December 31, 2025. Fourth Quarter HighlightsTotal revenue was $59.3 million for the fourth quarter of 2025, a decrease of 19% as compared to the same period last year, driven by customer cancellations and downsel

    3/12/26 4:30:00 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology

    $AI
    $BCAN
    $BFLY
    $COCH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Indaptus Therapeutics Inc.

    SC 13D/A - Indaptus Therapeutics, Inc. (0001857044) (Subject)

    11/26/24 4:11:08 PM ET
    $INDP
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Amendment: SEC Form SC 13G/A filed by Voyager Therapeutics Inc.

    SC 13G/A - Voyager Therapeutics, Inc. (0001640266) (Subject)

    11/14/24 6:13:11 PM ET
    $VYGR
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    Amendment: SEC Form SC 13G/A filed by LivePerson Inc.

    SC 13G/A - LIVEPERSON INC (0001102993) (Subject)

    11/14/24 5:21:06 PM ET
    $LPSN
    Computer Software: Prepackaged Software
    Technology